Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Regulation of opioid receptors by opioid antagonists: implications for rapid opioid detoxification

View through CrossRef
AbstractOpioid receptor antagonists have long been used in the diagnosis of opioid dependence and in the treatment of both opioid overdose and addiction. More recently they have been used in rapid opioid detoxification, a technique which has generated much ethical and scientific controversy. Because of this, the present review aims to integrate and summarize the current state of knowledge on adaptational changes to opioid systems as a result of antagonist administration. It is generally accepted that chronic treatment with an opioid antagonist results in opioid receptor upregulation. However, the mechanism(s) underlying this resultant opioid supersensitivity remain unresolved. In addition, there is not yet consensus regarding whether changes in opioid receptor number are directly responsible for the functional changes observed after chronic opioid antagonist treatment. Moreover, changes in opioid receptor number and sensitivity to opioid agonists and antagonists after chronic opioid antagonist treatment are dependent on dosing regimes as well as the kinetic properties of the antagonist itself. The role of these variables is appraised critically given the implication that an opioid antagonist can enhance functional responses. For example, such responses are an important consideration in the use of opioids because of possible adverse outcomes, such as overdose, after cessation of administration. Based on the literature discussed in this review it is concluded that caution is essential in the use of opioid antagonists for rapid opioid detoxification.
Title: Regulation of opioid receptors by opioid antagonists: implications for rapid opioid detoxification
Description:
AbstractOpioid receptor antagonists have long been used in the diagnosis of opioid dependence and in the treatment of both opioid overdose and addiction.
More recently they have been used in rapid opioid detoxification, a technique which has generated much ethical and scientific controversy.
Because of this, the present review aims to integrate and summarize the current state of knowledge on adaptational changes to opioid systems as a result of antagonist administration.
It is generally accepted that chronic treatment with an opioid antagonist results in opioid receptor upregulation.
However, the mechanism(s) underlying this resultant opioid supersensitivity remain unresolved.
In addition, there is not yet consensus regarding whether changes in opioid receptor number are directly responsible for the functional changes observed after chronic opioid antagonist treatment.
Moreover, changes in opioid receptor number and sensitivity to opioid agonists and antagonists after chronic opioid antagonist treatment are dependent on dosing regimes as well as the kinetic properties of the antagonist itself.
The role of these variables is appraised critically given the implication that an opioid antagonist can enhance functional responses.
For example, such responses are an important consideration in the use of opioids because of possible adverse outcomes, such as overdose, after cessation of administration.
Based on the literature discussed in this review it is concluded that caution is essential in the use of opioid antagonists for rapid opioid detoxification.

Related Results

Effectiveness of Perioperative Opioid Educational Initiatives: A Systematic Review and Meta-Analysis
Effectiveness of Perioperative Opioid Educational Initiatives: A Systematic Review and Meta-Analysis
BACKGROUND: Opioids are the most commonly prescribed analgesics in the United States. Current guidelines have proposed education initiatives to reduce the risk ...
High opioid dosage rapid detoxification of cancer patient in palliative care with the Raffaeli model
High opioid dosage rapid detoxification of cancer patient in palliative care with the Raffaeli model
Background: Chronic opioid administration can induce adverse drug-dependent events and tolerance and/or hyperalgesia development. Opioid rotation is the treatment option in this ca...
The use of chlordiazepoxide for outpatient gamma-butyrolactone (GBL) detoxification: An observational study
The use of chlordiazepoxide for outpatient gamma-butyrolactone (GBL) detoxification: An observational study
Background Various detoxification regimens are used for gamma-hydroxybutyrate (GHB) and gamma-butyrolactone (GBL), including diazepam, barbiturates, baclofen an...
Comparing the safety and efficacy of intravenous naloxone administration in opioid-naive and opioid-tolerant hospitalized oncology patients
Comparing the safety and efficacy of intravenous naloxone administration in opioid-naive and opioid-tolerant hospitalized oncology patients
Objective: To compare naloxone doses and clinical outcomes after emergency opioid reversal in opioid-naïve and opioid-tolerant inpatients.Design: Cross-sectional, retrospective cha...
Opioid use in young veterans
Opioid use in young veterans
Purpose: Data suggest an increase in prescription opioid abuse in recent years. Young veterans represent a group with major risk factors for prescription opioid abuse. The objectiv...

Back to Top